Ceribell director sells 8,286 shares under plan

Q: What insider transactions did Ceribell (CBLL) report for Josef Parvizi?

Ceribell reported that trusts associated with director Josef Parvizi sold a total of 8,286 shares of common stock in open-market transactions at around $20 per share, while also updating indirect share holdings across multiple trusts.

Q: At what prices were the Ceribell (CBLL) shares sold in this Form 4?

The reported Ceribell share sales occurred at a weighted average price of about $20 per share. Footnotes state trades were executed in multiple transactions at prices ranging from $20 to $20.02 per share, inclusive, in the open market.

Q: How many Ceribell (CBLL) shares did the Josef Parvizi Trust sell?

The Josef Parvizi Trust reported selling 8,286 shares of Ceribell common stock in total, through two open-market transactions of 6,986 shares and 1,300 shares, both reported at $20 per share in this Form 4 filing.

Q: What Ceribell (CBLL) shares remain held by trusts associated with Josef Parvizi?

After the reported transactions, the Josef Parvizi Trust holds 739,366 shares indirectly. The Innovation ACP Trust holds 907,911 shares, and the ACP 2021 Trust holds 369,088 shares, all as indirect ownership positions reported in the filing.

Ceribell, Inc. director Josef Parvizi reported automatic sales of common stock through trusts associated with him.

Accepted by SEC EDGAR 02/19/2026 - 04:17 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Ceribell, Inc. director Josef Parvizi reported automatic sales of common stock through trusts associated with him. A total of 8,286 shares were sold in open-market transactions at a weighted average price of about $20 per share under a Rule 10b5-1 trading plan adopted on August 18, 2025. The Josef Parvizi Trust now holds 739,366 shares indirectly, while the Innovation ACP Trust and ACP 2021 Trust hold 907,911 and 369,088 shares indirectly, respectively.

Insider Trade Summary

Net Seller: 8,286 shares

Net Sell 2 txns

Insider Parvizi Josef

Role Director

Sold 8,286 shs ($166K)

Type	Security	Shares	Price	Value
Sale	Common Stock	6,986	$20.00	$140K
Sale	Common Stock	1,300	$20.00	$26K
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 739,366 shares (Indirect, By Josef Parvizi Trust); Common Stock — 907,911 shares (Indirect, By Innovation ACP Trust); Common Stock — 369,088 shares (Indirect, By ACP 2021 Trust)

Footnotes (6)

F1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025.
F2. The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities.
F3. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20 to $20.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
F5. The Reporting Person is a co-trustee of the Innovation ACP Trust, and therefore may be deemed to share beneficial ownership of these securities.
F6. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Ceribell (CBLL) report for Josef Parvizi?

Ceribell reported that trusts associated with director Josef Parvizi sold a total of 8,286 shares of common stock in open-market transactions at around $20 per share, while also updating indirect share holdings across multiple trusts.

At what prices were the Ceribell (CBLL) shares sold in this Form 4?

The reported Ceribell share sales occurred at a weighted average price of about $20 per share. Footnotes state trades were executed in multiple transactions at prices ranging from $20 to $20.02 per share, inclusive, in the open market.

How many Ceribell (CBLL) shares did the Josef Parvizi Trust sell?

The Josef Parvizi Trust reported selling 8,286 shares of Ceribell common stock in total, through two open-market transactions of 6,986 shares and 1,300 shares, both reported at $20 per share in this Form 4 filing.

What Ceribell (CBLL) shares remain held by trusts associated with Josef Parvizi?

After the reported transactions, the Josef Parvizi Trust holds 739,366 shares indirectly. The Innovation ACP Trust holds 907,911 shares, and the ACP 2021 Trust holds 369,088 shares, all as indirect ownership positions reported in the filing.

Was the Ceribell (CBLL) insider sale made under a Rule 10b5-1 plan?

Yes. A footnote explains the reported sale transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025, indicating the trades were pre-arranged rather than discretionary market-timing decisions.

Does Josef Parvizi have beneficial ownership of Ceribell (CBLL) trust shares?

Footnotes state Josef Parvizi is trustee or co-trustee of the involved trusts and may be deemed to have beneficial ownership of the securities, but he disclaims beneficial ownership except to the extent of his pecuniary interest in those holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Parvizi Josef

(Last)

(First)

(Middle)

C/O CERIBELL, INC.

360 N. PASTORIA AVENUE

(Street)

SUNNYVALE

94085

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/17/2026		S⁽¹⁾		1,300	D	$20	746,352	I	By Josef Parvizi Trust⁽²⁾⁽³⁾
Common Stock	02/18/2026		S⁽¹⁾		6,986	D	$20⁽⁴⁾	739,366	I	By Josef Parvizi Trust⁽²⁾⁽³⁾
Common Stock								907,911	I	By Innovation ACP Trust⁽³⁾⁽⁵⁾
Common Stock								369,088	I	By ACP 2021 Trust⁽³⁾⁽⁶⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025.

2. The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities.

3. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20 to $20.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.

5. The Reporting Person is a co-trustee of the Innovation ACP Trust, and therefore may be deemed to share beneficial ownership of these securities.

6. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.

	/s/ Louisa Daniels, Attorney-in-Fact for Josef Parvizi	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR